Gilead Sciences Inc
NASDAQ: GILD
$97.20
+$5.51 (+6.0%)
Real Time Data Delayed 15 Min.
GILD Articles
The January 12 short interest data have been compared with the previous report, and short interest moves in the selected biotech stocks were mixed.
Published:
Last Updated:
Apple indicated that it will pay $38 billion in repatriation taxes under the new tax law. Apple says that it is already the largest U.S. taxpayer and that a payment of that size likely would be the...
Published:
Last Updated:
The top analyst upgrades, downgrades and other research calls from Tuesday include Amazon.com, Boeing, Chesapeake Energy, Eli Lilly, Gilead Sciences, Micron Thecnology, NVIDIA, Procter & Gamble...
Published:
Last Updated:
The December 29 short interest data have been compared with the previous report, and short interest in the selected biotech stocks was mixed.
Published:
Last Updated:
Merrill Lynch believes that this could be the year biotechs break out. The firm has a few picks, bad and good, that it believes will play a big role in the coming year.
Published:
Last Updated:
There can be some big biotech winners in 2018, given the changing landscape, and any of these 12 could be one.
Published:
Last Updated:
The December 15 short interest data have been compared with the previous report, and short interest in the selected biotech stocks increased.
Published:
Last Updated:
The top analyst upgrades, downgrades and other research calls from Wednesday include Alcoa, Extreme Networks, Gilead Sciences, MGIC, Micron, Noble Energy, Twitter, U.S. Steel and Wendy's
Published:
Last Updated:
The November 30 short interest data have been compared with the previous report, and short interest in most of the selected biotech stocks increased.
Published:
Last Updated:
One industry that could be a huge winner from tax reform, and may surprise some investors, is biotechnology, especially for the large cap leaders in the group.
Published:
Last Updated:
It is no secret that biotech stocks can bring great rewards for investors. They can also deliver serious pain. Fortunately, most of these are currently projected to deliver a solid 2018.
Published:
Last Updated:
The top analyst upgrades, downgrades and other research calls from Thursday include Amazon, Barrick Gold, Boston Scientific, Chipotle Mexican Grill, Gap, Gilead Sciences, Goldcorp and Workday.
Published:
Last Updated:
Gilead Sciences, Inc. (NASDAQ: GILD) saw its shares take a step back on Monday after an independent research firm downgraded the stock. Many investors have been hoping that the shares will pull out...
Published:
Last Updated:
The top analyst upgrades, downgrades and other research calls from Monday include Best Buy, Equifax, Gilead Sciences, MongoDB, NVIDIA, Rio Tinto, Teva Pharmaceutical and UPS.
Published:
Last Updated:
The October 31 short interest data have been compared with the previous report, and short interest in the selected biotech stocks was mixed.
Published:
Last Updated: